SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-329063
Filing Date
2013-08-09
Accepted
2013-08-09 15:35:12
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d548246d10q.htm 10-Q 544506
2 EX-31.1 d548246dex311.htm EX-31.1 9652
3 EX-31.2 d548246dex312.htm EX-31.2 9651
4 EX-32.1 d548246dex321.htm EX-32.1 5011
  Complete submission text file 0001193125-13-329063.txt   4658976

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nktr-20130630.xml EX-101.INS 409451
6 XBRL TAXONOMY EXTENSION SCHEMA nktr-20130630.xsd EX-101.SCH 37916
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktr-20130630_cal.xml EX-101.CAL 53280
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20130630_def.xml EX-101.DEF 91025
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20130630_lab.xml EX-101.LAB 274442
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20130630_pre.xml EX-101.PRE 180027
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 131026337
SIC: 2834 Pharmaceutical Preparations